Venture
![LOGO 5-01 LOGO 5-01](https://firstxfounder.com/wp-content/uploads/2018/07/LOGO-5-01-2-1024x1024.png)
Affiliations
Weill Cornell Medical College
Technologies
Therapeutic
Indication
Small molecular inhibitors of Rel/NF-kB
Website
jlabs.jnjinnovation.comAdditional Information
Women Founded
Our mission at ImmuneTarget is to develop novel Rel/NF-kB inhibitor drugs for cancer and autoimmune diseases.
ImmuneTarget, Inc. Team: